ADRB2 and chronic obstructive pulmonary disease: The pharmacological treatments, as summarized in the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines for managing stable COPD, include bronchodilators, β2-adrenergic receptor (β2AR) agonists and inhaled glucocorticosteroids [15].